Selected article for: "antiviral potential and IFN type"
Author: Park, Annsea; Iwasaki, Akiko
Title: Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
  • Cord-id: arcz8ku9
  • Document date: 2020_5_27
    • ID: arcz8ku9
    Snippet: Coronavirus disease 2019 (COVID-19) is a global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Without approved antiviral therapeutics or vaccines to this ongoing global threat, type I and type III interferons (IFNs) are currently being evaluated for their efficacy. Both the role of IFNs and the use of recombinant IFNs in two related, highly pathogenic coronaviruses, SARS-CoV and MERS-CoV, have been controversial in terms of their protective effects in the host.
    Document: Coronavirus disease 2019 (COVID-19) is a global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Without approved antiviral therapeutics or vaccines to this ongoing global threat, type I and type III interferons (IFNs) are currently being evaluated for their efficacy. Both the role of IFNs and the use of recombinant IFNs in two related, highly pathogenic coronaviruses, SARS-CoV and MERS-CoV, have been controversial in terms of their protective effects in the host. In this review, we describe the recent progress in our understanding of both type I and type III IFN-mediated innate antiviral responses against human coronaviruses and discuss the potential use of IFNs as a treatment strategy for COVID-19.

    Search related documents:
    Co phrase search for related documents
    • accurate understanding and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acid structure and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • activate signal and acute respiratory syndrome: 1, 2
    • activate transcription and acute respiratory syndrome: 1, 2, 3
    • acute illness and additional result: 1
    • acute illness and administration confer: 1
    • acute illness and administration confer protection: 1
    • acute respiratory syndrome and adaptive virus immune response: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome and additional result: 1, 2, 3, 4, 5
    • acute respiratory syndrome and administration confer: 1, 2, 3, 4
    • acute respiratory syndrome and administration confer protection: 1, 2
    • acute respiratory syndrome and administration timing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15